RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GRTX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Galera Therapeutics, Inc. stock price ended at $0.190 on Wednesday, after gaining 1.88%.
(Updated on May 01, 2024)

Sell candidate since Apr 26, 2024 Gain 1.99% PDF

The Galera Therapeutics, Inc. stock price gained 1.88% on the last trading day (Wednesday, 1st May 2024), rising from $0.186 to $0.190. During the last trading day the stock fluctuated 3.37% from a day low at $0.184 to a day high of $0.190. The price has been going up and down for this period, and there has been a -4.33% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 196 thousand more shares were traded than the day before. In total, 586 thousand shares were bought and sold for approximately $111.21 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -6.85% during the next 3 months and, with a 90% probability hold a price between $0.124 and $0.235 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GRTX Signals & Forecast

The Galera Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.190. On a fall, the stock will find some support from the long-term average at approximately $0.187. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Galera Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, April 25, 2024, and so far it has fallen -8.53%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Galera Therapeutics, Inc. stock

Galera Therapeutics, Inc. finds support from accumulated volume at $0.186 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0062 between high and low, or 3.37%. For the last week, the stock has had daily average volatility of 12.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GRTX) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Galera Therapeutics, Inc. to open at $0.188, and during the day (based on 14 day Average True Range), to move between $0.167 and $0.212, which gives a possible trading interval of +/-$0.0227 (+/-11.94%) up or down from last closing price. If Galera Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 23.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.192 (1.16%) than the support at $0.186 (2.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Galera Therapeutics, Inc. stock A Buy?

Galera Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.597 Sell Candidate Unchanged

Predicted Opening Price for Galera Therapeutics, Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$0.188 ( 1.02%) $0.190

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GRTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.194 2.25 %
R2 0.192 1.00 %
R1 0.190 0.229 %
Current price: 0.190
Support S1 0.185 -2.27 %
S2 0.184 -3.04 %
S3 0.182 -4.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.218 14.65 %
R2 0.198 4.53 %
R1 0.192 1.16 %
Current price 0.190
Support S1 0.186 -2.00%
S2 0.184 -3.06%
S3 0.166 -12.43%

FAQ

What is the symbol for Galera Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Galera Therapeutics, Inc. is GRTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Galera Therapeutics, Inc. Stock?
Galera Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Galera Therapeutics, Inc. Stock?
Galera Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Galera Therapeutics, Inc. Stock.

What's the current price of Galera Therapeutics, Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Galera Therapeutics, Inc. (GRTX) share was $0.190.

What is the 52-week high and low for Galera Therapeutics, Inc. Stock?
The 52-week high for Galera Therapeutics, Inc. Stock is $3.59 and the 52-week low is $0.0853.

What is the market capitalization of Galera Therapeutics, Inc. Stock?
As of the May 01, 2024, the market capitalization of Galera Therapeutics, Inc. is 10.324M.

When is the next earnings date for Galera Therapeutics, Inc.?
The upcoming earnings date for Galera Therapeutics, Inc. is Jun 13, 2024.
Click to get the best stock tips daily for free!

About Galera Therapeutics, Inc.

Galera Therapeutics. Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer... GRTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT